| First Author | Shen K | Year | 2021 |
| Journal | Cell Rep | Volume | 34 |
| Issue | 10 | Pages | 108835 |
| PubMed ID | 33691116 | Mgi Jnum | J:312321 |
| Mgi Id | MGI:6714847 | Doi | 10.1016/j.celrep.2021.108835 |
| Citation | Shen K, et al. (2021) Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination. Cell Rep 34(10):108835 |
| abstractText | In multiple sclerosis (MS) and other neurological diseases, the failure to repair demyelinated lesions contributes to axonal damage and clinical disability. Here, we provide evidence that Mertk, a gene highly expressed by microglia that alters MS risk, is required for efficient remyelination. Compared to wild-type (WT) mice, Mertk-knockout (KO) mice show impaired clearance of myelin debris and remyelination following demyelination. Using single-cell RNA sequencing, we characterize Mertk-influenced responses to cuprizone-mediated demyelination and remyelination across different cell types. Mertk-KO brains show an attenuated microglial response to demyelination but an elevated proportion of interferon (IFN)-responsive microglia. In addition, we identify a transcriptionally distinct subtype of surviving oligodendrocytes specific to demyelinated lesions. The inhibitory effect of myelin debris on remyelination is mediated in part by IFNgamma, which further impedes microglial clearance of myelin debris and inhibits oligodendrocyte differentiation. Together, our work establishes a role for Mertk in microglia activation, phagocytosis, and migration during remyelination. |
